Less Invasive Ventricular Enhancement

Enable volume reduction through micro-anchors designed to exclude left ventricular scarred myocardial tissue


The Revivent TC™

Transcatheter Ventricular Enhancement System

Click on image to view larger

Exclude anterior scarred myocardium from viable tissue

Reduce volume, radius, and wall tension

Restore conical morphology

Sternal sparing


A singular focus on the ventricle for less invasive heart failure treatments

Durable Clinical Data that Lasts (1-Year)

Studies have shown that the Revivent TC™ System achieves clinical benefits that result in significant volume reduction and EF improvement.

LVESVI Reduction
LVEDVI Reduction
LVEF Improvement
Exercise Capacity Improvement
QoL Improvement

What doctors have to say about The Revivent TC™ System

Case Study

Less-Invasive Treatment of Adverse Ventricular Remodeling Resulting in Reduction of Secondary Mitral Regurgitation


BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.

Our News

Contact Us

© 2022 BioVentrix. All Rights Reserved. Powered by MedTech Momentum
The Revivent TC™ trademark is a federally registered trademark owned by BioVentrix. Any unauthorized use is expressly prohibited.